These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8213063)

  • 21. CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls.
    Vrethem M; Dahle C; Ekerfelt C; Forsberg P; Danielsson O; Ernerudh J
    Acta Neurol Scand; 1998 Apr; 97(4):215-20. PubMed ID: 9576634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose intravenous corticosteroids in the treatment of multiple sclerosis.
    Ohno R; Hamaguchi K; Sowa K; Tanaka H; Watanabe Y
    Jpn J Med; 1987 May; 26(2):212-6. PubMed ID: 3626160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose methylprednisolone infusions in relapsing and in chronic progressive multiple sclerosis patients. One year follow-up.
    Bergamaschi R; Versino M; Raiola E; Citterio A; Cosi V
    Acta Neurol (Napoli); 1993 Feb; 15(1):33-43. PubMed ID: 8456594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of intravenous high dose methylprednisolone pulses on bone mineral density in patients with multiple sclerosis.
    Zorzon M; Zivadinov R; Locatelli L; Giuntini D; Toncic M; Bosco A; Nasuelli D; Bratina A; Tommasi MA; Rudick RA; Cazzato G
    Eur J Neurol; 2005 Jul; 12(7):550-6. PubMed ID: 15958096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype analysis of unstimulated lymphocytes and anti-CD3-stimulated proliferating T-cells from cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and other neurological diseases.
    Dufour A; Salmaggi A; Eoli M; La Mantia L; Milanese C; Nespolo A
    Int J Neurosci; 1993 Dec; 73(3-4):277-85. PubMed ID: 7513316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.
    Zivadinov R; Rudick RA; De Masi R; Nasuelli D; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    Neurology; 2001 Oct; 57(7):1239-47. PubMed ID: 11591843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS.
    Elovaara I; Lällä M; Spåre E; Lehtimäki T; Dastidar P
    Neurology; 1998 Dec; 51(6):1703-8. PubMed ID: 9855526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on activation variables in multiple sclerosis.
    Fredrikson S
    Acta Neurol Scand Suppl; 1988; 115():1-103. PubMed ID: 2838999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes of the MS functional composite and EDSS during and after treatment of relapses with methylprednisolone in patients with multiple sclerosis.
    Patzold T; Schwengelbeck M; Ossege LM; Malin JP; Sindern E
    Acta Neurol Scand; 2002 Mar; 105(3):164-8. PubMed ID: 11886358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis.
    Barnes D; Hughes RA; Morris RW; Wade-Jones O; Brown P; Britton T; Francis DA; Perkin GD; Rudge P; Swash M; Katifi H; Farmer S; Frankel J
    Lancet; 1997 Mar; 349(9056):902-6. PubMed ID: 9093250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses.
    La Mantia L; Eoli M; Milanese C; Salmaggi A; Dufour A; Torri V
    Eur Neurol; 1994; 34(4):199-203. PubMed ID: 7915989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, placebo-controlled, randomized, crossover trial of high-dose methylprednisolone in patients with chronic progressive form of multiple sclerosis.
    Cazzato G; Mesiano T; Antonello R; Monti F; Carraro N; Torre P; Bosco A; Cargnelutti D
    Eur Neurol; 1995; 35(4):193-8. PubMed ID: 7671978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cells undergo unique compartmentalized redistribution in multiple sclerosis.
    Haas J; Bekeredjian-Ding I; Milkova M; Balint B; Schwarz A; Korporal M; Jarius S; Fritz B; Lorenz HM; Wildemann B
    J Autoimmun; 2011 Dec; 37(4):289-99. PubMed ID: 21924866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of high-dose steroid therapy on T-cell subpopulations. A longitudinal study in MS patients.
    Gallo P; Chiusole M; Sanzari M; Sivieri S; Piccinno MG; Argentiero V; Rizzotti P; Tavolato B
    Acta Neurol Scand; 1994 Feb; 89(2):95-101. PubMed ID: 8191883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis.
    Pitzalis C; Sharrack B; Gray IA; Lee A; Hughes RA
    J Neuroimmunol; 1997 Apr; 74(1-2):62-8. PubMed ID: 9119980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte subpopulations in the blood and cerebrospinal fluid of multiple sclerosis patients in active disease.
    Rukavina D; Sepcić J; Dorić M; Ledić P; Zaputović L; Eberhardt P
    Acta Neurol Scand; 1984 Mar; 69(3):182-5. PubMed ID: 6609518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in multiple sclerosis.
    Manconi PE; Marrosu MG; Cianchetti C; Ennas MG; Mangoni A; Zaccheo D
    Acta Neurol Scand; 1980 Sep; 62(3):165-75. PubMed ID: 6971039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prospective assessment of the treatment of multiple sclerosis relapses with oral high-dose methylprednisolone: response and tolerability data].
    Pascual AM; Boscá I; Escutia M; Bernat A; Coret F; Casanova B
    Neurologia; 2008 Mar; 23(2):73-7. PubMed ID: 17641984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cells producing GM-CSF and IL-13 are enriched in the cerebrospinal fluid of relapsing MS patients.
    Ghezzi L; Cantoni C; Cignarella F; Bollman B; Cross AH; Salter A; Galimberti D; Cella M; Piccio L
    Mult Scler; 2020 Sep; 26(10):1172-1186. PubMed ID: 31237799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gamma delta T cell distribution in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis.
    Droogan AG; Crockard AD; Hawkins SA; McNeill TA
    J Neurol Sci; 1994 Nov; 126(2):172-7. PubMed ID: 7853024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.